JOA - 2026-11-13 - Journal Article; Review
Detrimental Mental Health Outcomes Following Periprosthetic Joint Infection: A Systematic Literature Review.
Shehadeh TH, Lizcano JD, Villa JM, Mont MA, Higuera-Rueda CA
Topics
Key Takeaway
PJI carries a depression prevalence of 27.3–36.1% and anxiety prevalence up to 29.8%, with two-stage revision spacer intervals associated with the greatest psychological distress across 67 included studies.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This PRISMA-compliant systematic review asked whether PJI treatment is associated with measurable psychological morbidity using validated PRO instruments (SF-12, SF-36, EQ-5D, PROMIS). Across 67 studies, depression prevalence ranged 27.3–36.1% and anxiety reached 29.8%, both exceeding general population and aseptic revision comparators. Mental health improved after reimplantation but remained persistently impaired, with failed treatment and chronic PJI carrying the highest psychosocial burden.
Key Limitation
Most included studies did not separate outcomes by treatment success versus failure, making it impossible to determine whether psychological morbidity reflects the infection itself, the treatment burden, or persistent functional impairment after eradication.
Original Abstract
INTRODUCTION
Periprosthetic joint infection (PJI) remains one of the most devastating complications following total joint arthroplasty. While treatment success has traditionally been defined by infection eradication and implant survivorship, growing evidence suggests that PJI is associated with substantial psychological morbidity and diminished health-related quality-of-life. This review systematically evaluated the current literature regarding mental health outcomes following treatment for PJI.
METHODS
A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four electronic databases were searched for studies reporting validated patient-reported mental health or quality-of-life outcomes following treatment for PJI. Studies reporting depression, anxiety, or mental health-related patient-reported outcome measures, including the Short Form-12, Short Form-36, EuroQol 5-Dimension, and Patient-Reported Outcomes Measurement Information System, were included. Data were extracted and qualitatively synthesized. A total of 67 studies met inclusion criteria.
RESULTS
Patients undergoing treatment for PJI demonstrated a trend towards worse mental health compared to the general population, primary arthroplasty, and aseptic revision cohorts. Reported prevalence of depression ranged from 27.3 to 36.1%, with anxiety prevalence reaching up to 29.8%. A two-stage revision arthroplasty, particularly during spacer treatment intervals, was associated with the greatest psychological distress. Mental health outcomes generally improved following reimplantation, albeit with persistent impairments. More invasive procedures, failed treatment, and chronic PJI were associated with a higher psychosocial burden.
DISCUSSION
A PJI is associated with substantial and often persistent psychological and physical morbidity. Mental health represents a critical component of the overall disease burden and may not be adequately reflected in traditional definitions of treatment success. Multiple studies suffer from limited sample size and lack of separation between successful and failed treatment procedures. Standardized assessment of psychological outcomes and multidisciplinary treatment approaches are warranted as part of patient-centered care and measurement of long-term patient recovery following PJI treatment.